Seaton, Kelly E. http://orcid.org/0000-0002-2009-3270
Spreng, Rachel L. http://orcid.org/0000-0003-1254-0760
Abraha, Milite
Reichartz, Matthew
Rojas, Michelle
Feely, Frederick II
Huntwork, Richard H. C.
Dutta, Sheetij
Mudrak, Sarah V.
Alam, S. Munir
Gregory, Scott
Jongert, Erik
Coccia, Margherita http://orcid.org/0000-0003-1947-4735
Ulloa-Montoya, Fernando
Wille-Reece, Ulrike
Tomaras, Georgia D. http://orcid.org/0000-0001-8076-1931
Dennison, S. Moses http://orcid.org/0000-0003-1198-9179
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388, OPP1151372, OPP12109388)
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
United States Department of Defense | United States Army | Army Medical Command | Walter Reed Army Institute of Research
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
PATH Malaria Vaccine Initiative
GlaxoSmithKline
Bill and Melinda Gates Foundation
Article History
Received: 5 January 2021
Accepted: 30 July 2021
First Online: 30 August 2021
Competing interests
: E.J., F.U.M. and M.C. are employees of the GSK group of companies and hold shares or restricted shares in the GSK group of companies. G.D.T. was a recipient of a research subcontract through Duke University from GSK and Macrogenics for work unrelated to this study. U.W.R. became an employee of GSK group of companies during the review of this manuscript.